Nationwide Recall Issued for Lot of Hospira Hydromorphone Injection

Hospira has issued a voluntary nationwide recall of one lot of Hydromorphone Injection, according to the American Society of Anesthesiologists.

Advertisement

A single complaint reported that one Carpuject contained more than the 1mL labeled volume. If opioid pain medications, such as Hydromorphone, are overdosed, consequences could be life-threatening respiratory depression, low blood pressure and reduced heart rate.

The affected lot number is 12720LL, and its expiration date is Dec. 1, 2013.

More Articles on Product Recalls:
Recall Issued for Hospira Injectable Anesthesia Product
FDA Warns of Risk of Death From Codeine in Children Following Surgery
Covidien Initiates Voluntary Recall of Tracheostomy Tubes

Advertisement

Next Up in Anesthesia

Advertisement

Comments are closed.